Suven Life Sciences

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue3.242.692.474.705.58
Expenses42.3646.6353.9882.01107.51
EBITDA-37.58-42.59-50.15-75.99-100.57
EBIT-39.11-43.94-51.52-77.31-101.92
Profit Before Tax-39.12-43.94-51.52-77.31-101.92
Net Profit-39.12-43.94-51.52-77.31-101.92
Financial Ratios
Operating Profit Margin-2,334%-2,898%-2,682%-8,260%-3,579%
Net Profit Margin-2,430%-2,989%-2,755%-8,403%-3,627%
Earning Per Share (Diluted)-1.79-2.02-2.36-3.48-4.55
Dividends Per Share0.000.000.000.000.00